Caldwell Sutter Capital’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.6K Hold
500
0.01% 414
2025
Q4
$29.6K Hold
500
0.01% 427
2025
Q3
$27.6K Hold
500
0.01% 433
2025
Q2
$21.5K Hold
500
0.01% 452
2025
Q1
$19.8K Hold
500
0.01% 462
2024
Q4
$20.4K Hold
500
0.01% 473
2024
Q3
$19.5K Hold
500
0.01% 483
2024
Q2
$21.9K Hold
500
0.01% 474
2024
Q1
$23.9K Hold
500
0.01% 451
2023
Q4
$23.6K Hold
500
0.01% 436
2023
Q3
$23.8K Hold
500
0.01% 414
2023
Q2
$29.1K Buy
+500
New +$30K 0.02% 390

Other funds holding NGVT

Caldwell Sutter Capital's NGVT Position: Q1 2026 in Review

Caldwell Sutter Capital held its Ingevity (NGVT) position steady in Q1 2026 at 500 shares worth $35.6K. The position accounts for 0.01% of the portfolio, ranked #414.

Caldwell Sutter Capital first reported a position in NGVT in Q2 2023 and has held it in 12 quarters since. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Caldwell Sutter Capital held 500 shares of Ingevity worth $35.6K as of Q1 2026.
  • Caldwell Sutter Capital left its Ingevity share count unchanged in Q1 2026.
  • Ingevity made up 0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #414 holding.
  • Caldwell Sutter Capital first reported a position in Ingevity in Q2 2023 and has held it in 12 quarters since.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.